ORIGINAL RESEARCH

Nanostructured photosensitizer based on a tetracationic derivative of bacteriochlorin for antibacterial photodynamic therapy

Meerovich GA1,2, Akhlyustina EV2, Tiganova IG3, Makarova EA4, Philipova NI3, Romanishkin ID1, Alekseeva NV3, Lukianets EA4, Romanova YuM3, Loschenov VB1
About authors

1 Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow

2 Department of laser micro-, nano- and biotechnologies, Institute of engineering physics for biomedicine, National Research Nuclear University "MEPHI", Moscow

3 Laboratory of gene engineering of pathogenic microorganisms, N.F. Gamaleya National Research Center of Epidemiology and Microbiology, Moscow

4 Organic Intermediates and Dyes Institute, Moscow

Correspondеnce should be adressed: Gennady A. Meerovich
Vavilova, 38, Moscow, 119991;

Received: 2018-08-31 Accepted: 2018-09-27 Published online: 2018-12-31
|
  1. Park YS, Lee HB, Chin S et al. Acquisition of extensive drug-resistant Pseudomonas aeruginosa among hospitalized patients: risk factors and resistance mechanisms to carbapenems. Hosp Infect. 2011; 79 (1): 54–8. DOI: 10.1016/j.jhin.2011.05.014.
  2. Bertoloni G, Rossi F, Valduga G, Jori et al. Photosensitising activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios. 1992; 71 (286): 33–46.
  3. Nakonieczna J, Michta E, Rybicka M et al. Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol. 2010; (10): 323. https://DOI.org/10.1186/1471- 2180-10-323.
  4. Tavares A, Carvalho CMB, Faustino MA et al. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment. Marine Drugs. 2010; 8 (1): 91–105. DOI: 10.3390/md8010091.
  5. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease. Photochem Photobiol Sci. 2004; 3 (5): 436–50.
  6. Vera DM, Haynes MH, Ball AR et al. Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol. 2012; 88 (3): 499–511. DOI: 10.1111/j.1751-1097.2012.01087.x.
  7. Maisch T. Resistance in antimicrobial photodynamic inactivation of bacteria. Photochem Photobiol. 2015; 14 (8): 1518–26. DOI: 10.1039/c5pp00037h.
  8. Almeida A, Cunha A, Faustino MAF et al. Porphyrins as antimicrobial photosensitizing agents. In: Photodynamic Inactivation of Microbial Pathogens: Medical and Environmental Applications. Hamblin MR, Jori G, editors. London: RSC Publishing, 2011; р. 83–160.
  9. Wainwright M. Photodynamic antimicrobial chemotherapy. Antimicrob Chemother. 1998; 42 (1): 13–28.
  10. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother. 2000; 44 (8): 2086–92.
  11. Nikaido H. Prevention of drug access to bacterial targets: Permeability barrier and active efflux. Science. 1994; 264 (5157): 382–8.
  12. Moan J. Photochemistry and Photobiology. The photochemical yield of singlet oxygen from porphyrins in different states of aggregation. 1984; (39): 445–9. Available from: https://DOI. org/10.1111/j.1751-1097.1984.tb03873.x.
  13. Bjarnsholt Th, Jensen PO, Moser C, Hoiby N. Biofilm infections. Heidelberg: Springer, 2011.
  14. Tiganova IG, Makarova EA, Meerovich GA, Alekseeva NV, Tolordava ER, Zhizhimova YS et al. Photodynamic inactivation of pathogenic bacteria in biofilms using new synthetic bacteriochlorin derivatives. Biomedical Photonics. 2017; 6 (4): 27–36. Russian. Available from: https://DOI.org/10.24931/2413-9432-2017-6-4-27-36.
  15. Makarov DA, Kuznetsova NA, Yuzhakоva OA, Savina LP, Kaliya OL, Lukyanets EA et al. Effects of the degree of substitution on the physicochemical properties and photodynamic activity of zinc and aluminum phthalocyanine polycations. Russian Journal of Physical Chemistry A. 2009; 83 (6): 1044–50.
  16. Bystrov FG, Makarov VI, Pominova DV, Ryabova AV, Loschenov VB. Analysis of photoluminescence decay kinetics of aluminum phthalocyanine nanoparticles interacting with immune cells. Biomedical Photonics. 2016; 5 (1): 3–8. Russian. Available from: https://DOI.org/10.24931/2413-9432-2016-5-1-3-8.
  17. Juzenas P, Juzeniene A, Rotomskis R, Moan J. Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions. Journal of Photochemistry and Photobiology B: Biology. 2004; 75 (1–2): 107–10. DOI: 10.1016/j.jphotobiol. 2004.05.011.
  18. Dhami S, Phillips D. Comparison of the photophysics of an aggregating and non-aggregating aluminium phthalocyanine system incorporated into unilamellar vesicles. Journal of Photochemistry and Photobiology A: Chemistry. 1996; 100 (1–3): 77–84.
  19. Reddi E, Jori G. Reviews of Chemical Intermediates. 1988; (10): 241–68. Available from: https://DOI.org/10.1007/BF03155995
  20. Tominaga TT, Yusbmanov VE, Borissevitch IE, Imasato H, Tabak M. Aggregation phenomena in the complexes of iron tetraphenylporphine sulfonate with bovine serum albumin. Journal of Inorganic Biochemistry. 1997; (65): 235–44.
  21. Changenet-Barret P, Gustavsson T, Markovitsi D, Manet I, Monti S. Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy. Physical Chemistry Chemical Physics. 2013; 15 (8): 2937–44.